Literature DB >> 18705408

Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification.

Nüket Uzüm1, Gülen Akyol Omür Ataoğlu.   

Abstract

AIMS AND
BACKGROUND: Meningiomas are classified following the WHO system of 2000 into three grades, benign (grade I), atypical (grade II), and anaplastic (grade III). We investigated the relation between tumor grade and Ki-67 and bcl-2.
METHODS: In the present study, 246 cases of meningioma were reclassified according to the WHO 2000 system. The relationship between tumor grade and morphological parameters like pattern, mitotic index, cellularity, pleomorphism, nucleoli, small cell population with high nucleus/cytoplasmic ratio, necrosis and brain invasion was examined. Follow-up data were available for only 80 patients.
RESULTS: A correlation was found between all morphologic parameters except for brain invasion. These parameters were related to a poor prognosis. There was no statistically significant difference in the prognosis between WHO grade I and grade II, whereas these two grades collectively exhibited significantly better survival than WHO grade III. Immunohistochemical staining for Ki-67 and bcl-2 was performed, and correlations between their expressions and other clinicopathological findings were investigated. Ki-67 and bcl-2 expression was correlated with tumor grade, and the higher the tumor grade, the higher the Ki-67 and bcl-2 expression. In conclusion, tumor grade appeared to be the most important parameter for a prognosis of meningiomas.
CONCLUSIONS: Ki-67 and bcl-2 expression might participate in carcinogenesis and when used with the grading system could provide additional benefit in assessing the biological behavior of the tumor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18705408     DOI: 10.1177/030089160809400316

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  9 in total

Review 1.  Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Brain Tumor Pathol       Date:  2021-01-06       Impact factor: 3.298

Review 2.  Pediatric meningioma: current approaches and future direction.

Authors:  Rishi S Kotecha; Reimar C Junckerstorff; Sharon Lee; Catherine H Cole; Nicholas G Gottardo
Journal:  J Neurooncol       Date:  2011-01-04       Impact factor: 4.130

3.  The histopathological spectrum of human meningiomas.

Authors:  Thomas Backer-Grøndahl; Bjørnar H Moen; Sverre H Torp
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

4.  Immunohistochemical and genetic markers to distinguish hemangiopericytoma and meningioma.

Authors:  Penglai Zhao; Tongming Zhu; Qisheng Tang; Hongyi Liu; Jianhong Zhu; Wenbin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  BAG-1 expression in human meningioma and correlation with clinical characteristics.

Authors:  Kaiyu Zhou; Hanghuang Jin; Ting Zhou; Yongkang Luo
Journal:  Med Oncol       Date:  2013-01-16       Impact factor: 3.064

6.  The Study of MIB-1 LI and CD 34 As A Marker of Proliferative Activity and Angiogenesis in Different Grades of Meningioma.

Authors:  Harishkumar Bohra; Khushi Ram Rathi; Sharmila Dudani; Ashish Bohra; Sumit Vishwakarma; Kavita Sahai
Journal:  J Clin Diagn Res       Date:  2016-08-01

7.  Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence.

Authors:  Song-Yuan Fan; Jian-Dong Jiang; Jun Qian; Yi-Cheng Lu; Guo-Han Hu; Chun Luo; Wei-Dong Hou; Qi Wang
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 8.  Genetic/molecular alterations of meningiomas and the signaling pathways targeted.

Authors:  Patrícia Domingues; María González-Tablas; Álvaro Otero; Daniel Pascual; Laura Ruiz; David Miranda; Pablo Sousa; Jesús María Gonçalves; María Celeste Lopes; Alberto Orfao; María Dolores Tabernero
Journal:  Oncotarget       Date:  2015-05-10

9.  Optic nerve sheath meningioma in the first decade of life: case report and review of the literature.

Authors:  Mário L R Monteiro; Allan Christian P Gonçalves; Sheila Aparecida C Siqueira; Eloísa M M Gebrim
Journal:  Case Rep Ophthalmol       Date:  2012-08-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.